• About
    • Overview
    • Team
    • Contact
  • Our Science
    • About Epigenetics
    • Our Approach
    • Therapeutic Applications
  • Our Programs
    • Pipeline
    • EZH2
    • BET
    • Clinical Trials
    • Preclinical
    • Publications
  • Careers
    • Company Culture
    • Core Values
    • Join Us
  • Investors & Media
    • Investor Overview
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Investor Resources
Investors & Media

About

  • Overview
  • Team
  • Contact

Our Science

  • About Epigenetics
  • Our Approach
  • Therapeutic Applications

Our Programs

  • Pipeline
  • EZH2
  • BET
  • Clinical Trials
  • Preclinical
  • Publications

Careers

  • Company Culture
  • Core Values
  • Join Us

Investors & Media

  • Investor Overview
  • Stock Information
    • Stock Quote/Chart
  • News & Events
    • News Releases
    • Investor Calendar
    • Annual Report / Proxy / Annual Meeting
    • Presentations
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management & Board of Directors
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Contact IR

Stockholder Tools

  • Print Page
  • RSS Feeds
  • Email Alerts

Global - Contact

Investor Contact

Kia Khalaghpour, Ph.D.
Vice President, Investor Relations and Communications
Constellation Pharmaceuticals
+1-617-844-6859
kia.khaleghpour@constellationpharma.com

Media Contact

Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com

 

Scott Braunstein, M.D.

Director
  • Chair of the Audit Committee
  • Member of the Nominating and Corporate Governance Committee

Investors & Media

About

  • Overview
  • Team
  • Contact

Our Science

  • About Epigenetics
  • Our Approach
  • Therapeutic Applications

Our Programs

  • Pipeline
  • EZH2
  • BET
  • Clinical Trials
  • Preclinical
  • Publications

Careers

  • Company Culture
  • Core Values
  • Join Us

Investors & Media

  • Investor Overview
  • Stock Information
    • Stock Quote/Chart
  • News & Events
    • News Releases
    • Investor Calendar
    • Annual Report / Proxy / Annual Meeting
    • Presentations
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management & Board of Directors
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Contact IR

Stockholder Tools

  • Print Page
  • RSS Feeds
  • Email Alerts

Investor Contact

Kia Khalaghpour, Ph.D.
Vice President, Investor Relations and Communications
Constellation Pharmaceuticals
+1-617-844-6859
kia.khaleghpour@constellationpharma.com

Media Contact

Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com

 

constellation pharma logo

215 First Street, Suite 200
Cambridge, MA 02142
Contact Constellation

  • Facebook
  • Twitter
  • Linkedin
  • About
    • Overview
    • Team
    • Contact
  • Our Science
    • About Epigenetics
    • Our Approach
    • Therapeutic Applications
  • Our Programs
    • Pipeline
    • EZH2
    • BET
    • Clinical Trials
    • Preclinical
    • Publications
  • Careers
    • Company Culture
    • Core Values
    • Join Us
  • Investors & Media
    • Investor Overview
    • Stock Information
      • Stock Quote/Chart
    • News & Events
      • News Releases
      • Investor Calendar
      • Annual Report / Proxy / Annual Meeting
      • Presentations
    • Financial Information
      • SEC Filings
      • Quarterly Results
    • Corporate Governance
      • Governance Highlights
      • Management & Board of Directors
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Information Request
      • Email Alerts
      • Contact IR

© 2021 Constellation Pharmaceuticals. All Rights Reserved.

Legal

  • Terms of Use